The question of whether the ketogenic diet can “cure” schizophrenia has become the subject of scientific debate in recent years, especially with the increased interest in the so-called “metabolic psychiatry”. The existing literature, supported by authors in the field such as Zoltán Sarnyai, Christopher M. Palmer, Elisa Brietzke, Shebani Sethi and others, suggests that although the ketogenic diet may have beneficial effects in some patients, there is insufficient scientific evidence to consider it a “cure” for schizophrenia.

Schizophrenia is a complex neuropsychiatric disorder, with a multifactorial etiology involving genetic, neurobiological, inflammatory and metabolic. The standard treatment remains the use of antipsychotics and psychosocial interventions. However, some researchers have pointed out that patients with schizophrenia often show disorders in the metabolism of glucose and energy in the brain, which has led to the hypothesis that metabolic interventions such as the ketogenic diet may have a therapeutic role. The ketogenic diet, characterized by low carbohydrate and high fat consumption, changes the brain’s primary energy source from glucose to ketones, potentially affecting mitochondrial function, oxidative stress, and neurotransmitters.

There are several case reports and small studies in the literature that show significant improvements in symptoms. One of the earliest reports by Kraft and Westman described a patient with chronic schizophrenia who experienced resolution of symptoms after starting a ketogenic diet. Also, more recent pilot clinical studies, such as one led by Shebani Sethi at Stanford University, have reported improvements in psychiatric symptoms and metabolic health in patients with schizophrenia and bipolar disorder. However, these studies are limited by small sample size, lack of control groups, and non-randomized design, making the results preliminary and inconclusive.

On the other hand, systematic reviews and theoretical articles highlight several possible mechanisms through which the ketogenic diet may affect schizophrenia, including reducing neuroinflammation, improving mitochondrial function, and balancing neurotransmitters such as glutamate and GABA. A 2025 review by Chaves and colleagues summarizes the current evidence and concludes that although there is a promising biological basis, clinical evidence is still at an early stage and large controlled studies are required to confirm effectiveness.

It is important to note that the scientific community does not consider the ketogenic diet a cure for schizophrenia. Even authors who have contributed to this field, such as Christopher Palmer, point out that the reported cases represent remission (temporary reduction or disappearance of symptoms) and not complete recovery. Schizophrenia is generally considered a chronic disorder that is managed, not cured. Furthermore, the ketogenic diet is difficult to follow in the long term and may be associated with side effects or nutritional deficiencies if not properly monitored.

In conclusion, although the ketogenic diet represents an innovative and promising direction in the treatment of schizophrenia, especially within the metabolic approach to mental disorders, current evidence does not support the claim that it can “cure” this disease. It can be considered as a potential additional intervention in certain cases and under medical supervision, but further research is essential to determine its exact role in clinical practice.

We use cookies to improve the experience and display advertisements (Google AdSense).
By clicking “Accept”, you agree to the use of cookies according to
Privacy Policy
and
Cookies Policy.
You can reject non-necessary cookies by clicking “Reject”.

Source: prizrenpost